ClassID:

21647

A61K2300/00 - page 26 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#7501
20110288141
2011-11-24

LOCAL TOPICAL ADMINISTRATION FORMULATIONS CONTAINING FIPRONIL

#7502
20110288134
2011-11-24

COMPOSITION AND METHOD FOR TREATING FIBROSIS

#7503
20110288110
2011-11-24

METHODS FOR TREATING DISORDERS ASSOCIATED WITH HYPERLIPIDEMIA IN A MAMMAL

#7504
20110288105
2011-11-24

ELTOPRAZINE FOR THE TREATMENT OF L-DOPA-INDUCED DYSKINESIA

#7505
20110288101
2011-11-24

SURGICAL COMPOSITIONS CONTAINING SIGMA-RECEPTOR AGONISTS

#7506
20110288096
2011-11-24

Methods and compositions for treating or preventing erythema

#7507
20110288092
2011-11-24

Heterocyclic Inhibitors of MEK and Methods of Use Thereof

#7508
20110288079
2011-11-24

Tannate compositions, methods of making and methods of use

#7509
20110288064
2011-11-24

METHODS FOR TREATING DISORDERS ASSOCIATED WITH HYPERLIPIDEMIA IN A MAMMAL

#7510
20110288063
2011-11-24

NOVEL FUSED BRIDGED BICYCLIC HETEROARYL SUBSTITUTED 6-ALKYLIDENE PENEMS AS POTENT BETA-LACTAMASE INHIBITORS

#7511
20110288045
2011-11-24

WET GRANULATION OF TENOFOVIR, EMTRICITABINE AND EFAVIRENZ

#7512
20110288043
2011-11-24

Maintenance of platelet inhibition during antiplatelet therapy

#7513
20110288037
2011-11-24

Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System

#7514
20110288032
2011-11-24

ENZASTAURIN FOR THE TREATMENT OF CANCER

#7515
20110288019
2011-11-24

Methods of increasing platelet and hematopoietic stem cell production

#7516
20110288016
2011-11-24

Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies

#7517
20110288014
2011-11-24

METHODS AND COMPOSITIONS FOR DIABETES TREATMENT AND PREVENTION

#7518
20110288012
2011-11-24

Nutrition composition

#7519
20110288003
2011-11-24

Amide based glucagon and superfamily peptide prodrugs

#7520
20110287116
2011-11-24

USE OF JASMONATES FOR TREATING HEART FAILURE AND RELATED CARDIAC DISORDERS

#7521
20110287112
2011-11-24

PROSTATE CANCER PROGRESSION INHIBITOR AND PROGRESSION INHIBITION METHOD

#7522
20110287110
2011-11-24

COMBINATION CANCER TREATMENT

#7523
20110287109
2011-11-24

Compositions And Beverages Comprising Nutrients, Vitamins, Sugars, Cysteine, And/Or Sugar-Cysteine Products

#7524
20110287106
2011-11-24

COGNITIVE IMPAIRMENT AMELIORANT

#7525
20110287096
2011-11-24

MODIFIED GASTRORETENTIVE DRUG DELIVERY SYSTEM FOR AMINE DRUGS

#7526
20110287095
2011-11-24

Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans

#7527
20110287092
2011-11-24

Compositions comprising decitabine and tetrahydrouridine and uses thereof

#7528
20110287081
2011-11-24

BOLUS

#7529
20110287075
2011-11-24

ELECTRICITY-GENERATING PARTICULATES AND THE USE THEREOF

#7530
20110287074
2011-11-24

Antimicrobial Compositions, Methods of Manufacture Thereof and Articles Comprising the Same

#7531
20110287072
2011-11-24

Prebiotic formulations and methods of use

#7532
20110287068
2011-11-24

FIBRIN AND FIBRINOGEN MATRICES AND USES OF SAME

#7533
20110287062
2011-11-24

Chewable Formulation Comprising Alginate, Bicarbonate And Carbonate

#7534
20110287061
2011-11-24

Dietary composition and method for promoting healthy hair growth and melanogenesis

#7535
20110287045
2011-11-24

Enhanced immune response against infections

#7536
20110287033
2011-11-24

Use of ferritin to treat iron disorders

#7537
20110287026
2011-11-24

SIRT4 AND USES THEREOF

#7538
20110287023
2011-11-24

High affinity antibodies against HMGB1 and methods of use thereof

#7539
20110287011
2011-11-24

DDR1-binding agents and methods of use thereof

#7540
20110287006
2011-11-24

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT

#7541
20110287003
2011-11-24

TREATMENT METHODS

#7542
20110287002
2011-11-24

Antibodies against epidermal growth factor receptor (EGFR) and uses thereof

#7543
20110287001
2011-11-24

METHOD OF TREATMENT

#7544
20110286999
2011-11-24

METHODS FOR REVERSING MULTIPLE RESISTANCE IN ANIMAL CELLS

#7545
20110286998
2011-11-24

METHODS FOR TREATING AND PREVENTING CANCERS THAT EXPRESS THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS OF HORMONES AND RECEPTORS

#7546
20110286986
2011-11-24

Lactoferrin and angiogenin compositions and uses thereof

#7547
20110286979
2011-11-24

CHEMOSENSITIZATION BY BI-FUNCTIONAL SMALL HAIRPIN RNA (bi-shRNA)

#7548
20110286970
2011-11-24

METHOD FOR TREATING PARKINSON'S DISEASE

#7549
20110286969
2011-11-24

DEUTERATED COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS

#7550
20110286960
2011-11-24

CANCER THERAPY BY DOCETAXEL AND GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF)

#7551
20110286959
2011-11-24

Copolymers for suppression of autoimmune diseases, and methods of use

#7552
20110286945
2011-11-24

Compounds, formulations and methods for reducing skin wrinkles, creasing and sagging

#7553
20110286925
2011-11-24

Embolizing sclerosing hydrogel

#7554
20110281942
2011-11-17

Tautomycetin and tautomycetin analog biosynthesis

#7555
20110281941
2011-11-17

Combination of lycopene, polyphenol, and vitamins for the care of keratin materials

#7556
20110281935
2011-11-17

Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer

#7557
20110281932
2011-11-17

Methods to enhance T-cell mediated immune response

#7558
20110281920
2011-11-17

INJECTABLE PARASITICIDAL FORMULATIONS OF LEVAMISOLE AND MACROCYCLIC LACTONES

#7559
20110281916
2011-11-17

Migrastatin analogs and uses thereof

#7560
20110281905
2011-11-17

ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR

#7561
20110281902
2011-11-17

COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDYLAMINOBENZAMIDE COMPOUND AND A HSP90 INHIBITOR SUCH AS 17-AAG

#7562
20110281900
2011-11-17

Crystalline pharmaceutical

#7563
20110281892
2011-11-17

Method and formulation for cold treatment in adults and children with increased safety

#7564
20110281889
2011-11-17

Method of treating autism

#7565
20110281882
2011-11-17

Compositions and Methods for Treating, Controlling, Reducing, or Ameliorating Inflammatory Pain

#7566
20110281880
2011-11-17

METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIONS, AND METHODS OF MEASURING

#7567
20110281866
2011-11-17

Heterocyclic kinase inhibitors

#7568
20110281855
2011-11-17

And potent tapentadol dosage forms

#7569
20110281853
2011-11-17

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION

#7570
20110281852
2011-11-17

Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs

#7571
20110281839
2011-11-17

COMBINATION THERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS

#7572
20110281833
2011-11-17

Composition for the treatment of ear infections and method

#7573
20110281832
2011-11-17

Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase 1

#7574
20110281831
2011-11-17

NOVEL DERMACEUTICAL CREAM MADE USING SODIUM FUSIDATE, ANTIFUNGALS AND STEROIDS

#7575
20110281829
2011-11-17

Composition

#7576
20110281814
2011-11-17

METHODS AND COMPOSITIONS FOR TREATING BREAST CANCER

#7577
20110281813
2011-11-17

METHOD OF TREATING C-KIT POSITIVE RELAPSED ACUTE MYELOID LEUKEMIA

#7578
20110281811
2011-11-17

Use Of Leukotriene Inhibitors For Treating Lung Diseases In Prematurely Born Infants

#7579
20110281809
2011-11-17

Methods and compositions for rapid treatment of otitis externa

#7580
20110281794
2011-11-17

COMPOSITION COMPRISING NOR-ADRENALINE AND AMPHETAMINE FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR

#7581
20110281788
2011-11-17

ANTI FUNGAL THERAPY

#7582
20110281322
2011-11-17

INHIBITORS OF BRUTON'S TYROSINE KINASE

#7583
20110280977
2011-11-17

COMPOSITION FOR RELIEVING AND PREVENTING HANGOVER AND BEVERAGE COMPRISING COMPOSITION

#7584
20110280973
2011-11-17

Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport

#7585
20110280972
2011-11-17

PREPARATION FOR THE TREATMENT OF TINNITUS

#7586
20110280971
2011-11-17

BERRY OILS AND PRODUCTS

#7587
20110280969
2011-11-17

PETROLEUM-FREE COMPOSITIONS FOR SKIN CARE AND OTHER APPLICATIONS, AND METHODS OF MAKING SAME

#7588
20110280966
2011-11-17

Dosing regimens and methods of treatment using carbon monoxide

#7589
20110280964
2011-11-17

Composition and method of treating hearing loss

#7590
20110280963
2011-11-17

Combination therapy for the treatment of cancer

#7591
20110280960
2011-11-17

THICK PINE NEEDLE EXTRACT COMPOSITION FOR CAPSULATION

#7592
20110280952
2011-11-17

Platelet Lysate and Bioadhesive Compositions Thereof for the Treatment of Mucositis

#7593
20110280951
2011-11-17

Composition from Sphaeranthus indicus and Garcinia mangostana for the control of metabolic syndrome

#7594
20110280945
2011-11-17

NOVEL METHOD FOR THE PREPARATION OF GRANULATES OF ACTIVE CONSTITUENTS, AND GRANULATES AS OBTAINED

#7595
20110280941
2011-11-17

COMPOSITIONS OF PROTON PUMP INHIBITORS AND INSULIN SECRETAGOGUES, AND METHODS OF THEIR USE TO TREAT DIABETES

#7596
20110280934
2011-11-17

Increased Expression of Specific Antigens

#7597
20110280932
2011-11-17

Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

#7598
20110280928
2011-11-17

Wound care device having fluid transfer properties

#7599
20110280923
2011-11-17

Bolus devices for the delivery of active agents to animals

#7600
20110280913
2011-11-17

Methods and Compositions for Delivering Therapeutic Agents in the Treatment of B-Cell Related Disorders

#7601
20110280909
2011-11-17

METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE

#7602
20110280903
2011-11-17

IMMUNOSTIMULATORY COMBINATIONS

#7603
20110280886
2011-11-17

TREATING CANCER BY MODULATING MNK

#7604
20110280869
2011-11-17

METHODS OF PREVENTING OR TREATING INFLAMMATORY OR AUTOIMMUNE DISORDERS BY ADMINISTERING CD2 ANTAGONISTS IN COMBINATION WITH OTHER PROPHYLACTIC OR THERAPEUTIC AGENTS

#7605
20110280862
2011-11-17

GEP AND DRUG TRANSPORTER REGULATION, CANCER THERAPY AND PROGNOSIS

#7606
20110280855
2011-11-17

VITAMIN C COMPOSITIONS

#7607
20110280854
2011-11-17

Compositions and methods for the treatment or the prevention of infections and for the eradication or reduction of surfaces

#7608
20110280853
2011-11-17

Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces

#7609
20110280852
2011-11-17

Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline

#7610
20110280851
2011-11-17

Compositions Comprising Cranberry Extract and Methods of Use Thereof

#7611
20110280849
2011-11-17

TUMOR SUPPRESSION USING HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATORY COMPOUNDS

#7612
20110280848
2011-11-17

COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF

#7613
20110280845
2011-11-17

TREATMENT OF RHEUMATOID ARTHRITIS USING PLACENTAL STEM CELLS

#7614
20110280843
2011-11-17

Treatment of psoriasis using placental stem cells

#7615
20110280840
2011-11-17

Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota

#7616
20110280832
2011-11-17

Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders

#7617
20110280831
2011-11-17

COMBINATIONS COMPRISING METHOTREXATE AND DHODH INHIBITORS

#7618
20110280827
2011-11-17

METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES

#7619
20110280809
2011-11-17

Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment

#7620
20110280763
2011-11-17

LIGHT-ACTIVATED DISINFECTION SYSTEM

#7621
20110275999
2011-11-10

Drug delivery device

#7622
20110275720
2011-11-10

Methods for concomitant administration of colchicine and a second active agent

#7623
20110275718
2011-11-10

Pharmaceutical composition of ibuprofen and paracetamol and methods of using the same

#7624
20110275713
2011-11-10

Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements

#7625
20110275709
2011-11-10

TELLURIUM-CONTAINING COMPOUNDS FOR AFFECTING MALE'S FERTILITY FOLLOWING CHEMOTHERAPY AND/OR RADIOTHERAPY

#7626
20110275702
2011-11-10

DNA nanostructures that promote cell-cell interaction and use thereof

#7627
20110275696
2011-11-10

Thioxanthone-based autophagy inhibitor therapies to treat cancer

#7628
20110275691
2011-11-10

METHODS OF TREATING HEADACHES USING 5-HT AGONISTS IN COMBINATION WITH LONG-ACTING NSAIDS

#7629
20110275672
2011-11-10

METHODS FOR TREATING CANCERS USING POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE

#7630
20110275664
2011-11-10

Method for treating drug and behavioral addictions

#7631
20110275658
2011-11-10

Opioid-containing oral pharmaceutical compositions and methods

#7632
20110275649
2011-11-10

Combination therapy for the prevention of statin induced diabetes

#7633
20110275617
2011-11-10

Ophthalmic composition

#7634
20110275616
2011-11-10

Combination Analgesic Employing Opioid and Neutral Antagonist

#7635
20110275597
2011-11-10

Pharmaceutical composition

#7636
20110275594
2011-11-10

Oral dosage form

#7637
20110275591
2011-11-10

COCKTAIL FOR MODULATION OF ALZHEIMER'S DISEASE

#7638
20110275587
2011-11-10

Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis

#7639
20110275584
2011-11-10

PREVENTION AND TREATMENT OF INFLAMMATION-INDUCED AND/OR IMMUNE-MEDIATED BONE LOSS

#7640
20110275577
2011-11-10

METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS

#7641
20110275571
2011-11-10

Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia

#7642
20110275561
2011-11-10

Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

#7643
20110275558
2011-11-10

Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders

#7644
20110275151
2011-11-10

Methods and compositions for repair of cartilage using an in vivo bioreactor

#7645
20110274791
2011-11-10

MULTIVITAMIN/MINERAL FORMULATION TO COMBAT THE EFFECTS OF ENVIRONMENTAL STRESS; IMPROVED IMMUNITY AND IMPROVE ENERGY WHILE ADDRESSING VITAMIN AND MINERAL DEFICIENCIES WITHOUT THE NEGATIVE SIDE EFFECTS OF A MEGA DOSE NUTRITIONAL SUPPLEMENT

#7646
20110274778
2011-11-10

Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases

#7647
20110274776
2011-11-10

COMPOSITIONS COMPRISING EXTRACTS OF SOUTHERNWOOD AND AN AMINE COMPOUND

#7648
20110274775
2011-11-10

EXTRACTS OF SOUTHERNWOOD AND TOPICAL USES THEREOF

#7649
20110274773
2011-11-10

Copper(I) Chloride Complex Of Nicotinic Acid And Pharmaceutical Compositions Containing The Same

#7650
20110274772
2011-11-10

Ointment for the topical treatment of haemorrhoids

#7651
20110274771
2011-11-10

Prenatal Syptomatic Kit

#7652
20110274765
2011-11-10

Flavored colonic cleansing system

#7653
20110274764
2011-11-10

FLAVORED COLONIC CLEANSING SYSTEM

#7654
20110274758
2011-11-10

Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes

#7655
20110274757
2011-11-10

Nucleic acid delivery vehicle and uses thereof

#7656
20110274755
2011-11-10

SUPPORTIVE TREATMENT OF LIVER DISEASE

#7657
20110274742
2011-11-10

Cartilage repair systems and applications utilizing a glycosaminoglycan mimic

#7658
20110274728
2011-11-10

Compositions and Methods for Alleviating Hyposalivation and for Providing Oral Comfort

#7659
20110274724
2011-11-10

Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide

#7660
20110274722
2011-11-10

Food containing a probiotic and an isolated β-glucan and methods of use thereof

#7661
20110274716
2011-11-10

Compositions containing fucoxanthin extract

#7662
20110274705
2011-11-10

Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells

#7663
20110274703
2011-11-10

Detection and treatment of non-dermal fibrosis

#7664
20110274697
2011-11-10

NOVEL USES

#7665
20110274686
2011-11-10

Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan

#7666
20110274680
2011-11-10

Chemical composition and its delivery for lowering the risks of alzheimer's, cardiov ascular and type-2 diabetes diseases

#7667
20110274679
2011-11-10

Compositions and Methods of SIRT Activation

#7668
20110274666
2011-11-10

METHOD OF ENGRAFTING CELLS FROM SOLID TISSUES

#7669
20110274652
2011-11-10

Methods for Treating Hepatitis C Virus Infection

#7670
20110274651
2011-11-10

Noscapine and Noscapine Analogs and Their Use in treating Infectious Diseases by Tubulin Binding Inhibition

#7671
20110274646
2011-11-10

Compounds and combinations

#7672
20110274631
2011-11-10

AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA

#7673
20110274628
2011-11-10

NICOTINE-CONTAINING PHARMACEUTICAL COMPOSITIONS

#7674
20110270218
2011-11-03

Drug delivery device

#7675
20110270215
2011-11-03

COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR

#7676
20110270212
2011-11-03

PHARMACOKINETIC CONTROL FOR OPTIMIZED INTERFERON DELIVERY

#7677
20110270165
2011-11-03

COMPOSITIONS FOR TREATMENT AND USE OF A PALATAL PATCH

#7678
20110270011
2011-11-03

Use of opioids or opioid mimetics for the treatment of resistant cancer patients

#7679
20110269950
2011-11-03

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

#7680
20110269947
2011-11-03

Apo-2 ligand/trail formulations

#7681
20110269852
2011-11-03

METHODS AND MECHANISMS INVOLVING HYPERPIGMENTATION PARTICULARLY FOR AFRICAN AMERICAN SKIN

#7682
20110269839
2011-11-03

ANTI-SNORING COMPOSITION CONTAINING A TERMOGELLING POLYMER

#7683
20110269833
2011-11-03

Continuous administration of dopa decarboxylase inhibitors and compositions for same

#7684
20110269808
2011-11-03

Compositions comprising (S)-2-amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases

#7685
20110269802
2011-11-03

METHOD OF DELIVERY OF PERISHABLE LIQUID MIXTURES USING MIXING CAP AND CONTAINER SYSTEM

#7686
20110269796
2011-11-03

Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines

#7687
20110269795
2011-11-03

Use of glucosidase inhibitors for therapy of mucovisidosis

#7688
20110269794
2011-11-03

External preparation for athlete's foot treatment

#7689
20110269786
2011-11-03

TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME IN DIABETIC PATIENTS USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES

#7690
20110269782
2011-11-03

USE OF NMDA ACTIVITY ENHANCERS TO TREAT HYPERSOMNIA, REDUCED WAKEFULNESS OR REDUCED VIGILANCE

#7691
20110269777
2011-11-03

METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA USING ANTIPSYCHOTIC COMBINATION THERAPY

#7692
20110269764
2011-11-03

THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF SYNAPSE FUNCTION

#7693
20110269762
2011-11-03

METHODS FOR TREATING ATRIAL FIBRILLATION AND REDUCING STROKE RATE IN ATRIAL FIBRILLATION PATIENTS

#7694
20110269758
2011-11-03

NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS

#7695
20110269755
2011-11-03

COMPOSITIONS AND METHODS FOR TREATING VASCULAR, AUTOIMMUNE, AND INFLAMMATORY DISEASES

#7696
20110269750
2011-11-03

Roflumilast for the treatment of diabetes mellitus type 2

#7697
20110269728
2011-11-03

Methods and compositions related to glucocorticoid receptor antagonists and breast cancer

#7698
20110269727
2011-11-03

COMPOSITION TO REDUCE ALLODYNIC BACK PAIN AND RELATED METHOD OF USE

#7699
20110269724
2011-11-03

Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries

#7700
20110269720
2011-11-03

MINOCYCLINE AND RIFAMPIN MICROPARTICLES

#7701
20110269719
2011-11-03

PHARMACEUTICAL COMPOSITIONS WITH PHOSPHONIUM ANTIMICROBIAL AGENTS

#7702
20110269717
2011-11-03

NEUROGENESIS BY MODULATING ANGIOTENSIN

#7703
20110269702
2011-11-03

Polyacetylenic compounds for protecting against pancreatic islet atrophy

#7704
20110269692
2011-11-03

ALPHA-FETOPROTEIN PEPTIDES AND USES THEREOF

#7705
20110269681
2011-11-03

Prolactin induced increase in neural stem cell numbers

#7706
20110269675
2011-11-03

Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions

#7707
20110269666
2011-11-03

Method and drug composition for treating septic shock hypotension

#7708
20110269186
2011-11-03

Antibodies against vascular endothelial growth factor receptor-1

#7709
20110268829
2011-11-03

Quality of life for hepatitis C patients with a formulation for administration to the oral mucosa including and N-acetyl D-glucosamine

#7710
20110268827
2011-11-03

Vision-protecting composition with prophylactic and therapeutic activity against diabetes or diabetic complications

#7711
20110268825
2011-11-03

Compositions that include anthocyanidins and methods of use

#7712
20110268820
2011-11-03

Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue

#7713
20110268818
2011-11-03

NGAL-BINDING SIDEROPHORES AND USE THEREOF TO TREAT IRON DEFICIENCY AND IRON OVERLOAD

#7714
20110268817
2011-11-03

COMPOUNDS USEFUL FOR THE PREVENTION OR TREATMENT OF ACCOMODATIVE ASTHENOPIA

#7715
20110268811
2011-11-03

Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans

#7716
20110268798
2011-11-03

ORALLY DISNTEGRATING TABLETS FOR THE TREATMENT OF PAIN

#7717
20110268793
2011-11-03

Kits for nutrition supplementation

#7718
20110268754
2011-11-03

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

#7719
20110268743
2011-11-03

Probiotics, secretory IgA and inflammation

#7720
20110268732
2011-11-03

Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof

#7721
20110268729
2011-11-03

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS BY NOGO-A-ANTAGONIST

#7722
20110268725
2011-11-03

Anti-NGF antibodies for the treatment of various disorders

#7723
20110268722
2011-11-03

COMBINATION THERAPIES WITH MITOCHONDRIAL-TARGETED ANTI-TUMOR AGENTS

#7724
20110268721
2011-11-03

Therapy Regimens, Dosing Regimens And Stable Medicaments For The Treatment Of Pompe Disease

#7725
20110268720
2011-11-03

Formulations of 5-fluorocytosine and uses thereof

#7726
20110268719
2011-11-03

Annatto extract compositions, including geranyl geraniols and methods of use

#7727
20110268717
2011-11-03

Herbal-based compositions for alleviating symptoms associated with autism

#7728
20110268702
2011-11-03

LACTOBACILLUS PARACASEI AND WEIGHT CONTROL

#7729
20110268700
2011-11-03

Dosage regimens for HCV combination therapy

#7730
20110268694
2011-11-03

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#7731
20110268678
2011-11-03

Vitamin D promoting sunscreen

#7732
20110268662
2011-11-03

Functionalized nanoceria composition for ophthalmic treatment

#7733
20110263682
2011-10-27

METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50-53

#7734
20110263664
2011-10-27

Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer

#7735
20110263663
2011-10-27

Synthesis of epothilones, intermediates thereto, analogues and uses thereof

#7736
20110263653
2011-10-27

Migrastatin analog compositions and uses thereof

#7737
20110263644
2011-10-27

Compounds and methods for treatment of stroke

#7738
20110263642
2011-10-27

METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS

#7739
20110263641
2011-10-27

Isoxazolines for controlling invertebrate pests

#7740
20110263638
2011-10-27

Therapeutic agent for glaucoma comprising rho kinase inhibitor and ß- blocker

#7741
20110263631
2011-10-27

COMBINATION OF A SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR AND AN OPIOID AGONIST FOR THE TREATMENT OF PAIN

#7742
20110263621
2011-10-27

NEW COMBINATION OF ACTIVE INGREDIENTS CONTAINING AN a1-ANTAGONIST AND A PDE 4 INHIBITOR

#7743
20110263574
2011-10-27

PIRENZEPINE AS OTOPROTECTIVE AGENT

#7744
20110263568
2011-10-27

Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker

#7745
20110263563
2011-10-27

Ansamycin hydroquinone compositions

#7746
20110263552
2011-10-27

MODULATION OF SIDE EFFECT PROFILE OF 5-ALPHA REDUCTASE INHIBITOR THERAPY

#7747
20110263551
2011-10-27

Method for treating otitis externa

#7748
20110263547
2011-10-27

C-19 steroids for specific therapeutic uses

#7749
20110263545
2011-10-27

HEPATOPROTECTANT ACETAMINOPHEN MUTUAL PRODRUGS

#7750
20110263542
2011-10-27

METHODS TO TREAT PAIN USING AN ALPHA-2 ADRENERGIC AGONIST AND AN ENDOTHELIN ANTAGONIST

#7751
20110263540
2011-10-27

SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS

#7752
20110263537
2011-10-27

Co-administration of steroids and Zoledronic acid to prevent and treat side effects from Zoledronic acid infusion

#7753
20110263528
2011-10-27

Antimicrobial compositions

#7754
20110263525
2011-10-27

Drug composition cytotoxic for pancreatic cancer cells

#7755
20110263524
2011-10-27

SNS-595 AND METHODS OF USING THE SAME

#7756
20110263522
2011-10-27

ANTITUMOUR COMPOSITIONS CONTAINING TAXANE DERIVATIVES

#7757
20110263506
2011-10-27

Peptides having an ACE inhibiting effect

#7758
20110263505
2011-10-27

Whey Protein Hydrolysate Containing Tryptophan Peptide Consisting of Alpha Lactalbumin and the Use Thereof

#7759
20110263498
2011-10-27

Method and composition for enhancement of male erectile function

#7760
20110263489
2011-10-27

Combination therapy to combat helminth resistance

#7761
20110262961
2011-10-27

Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation

#7762
20110262894
2011-10-27

VACCINE AGAINST INFECTIOUS AGENTS HAVING AN INTRACELLULAR PHASE, COMPOSITION FOR THE TREATMENT AND PREVENTION OF HIV INFECTIONS, ANTIBODIES AND METHODS OF DIAGNOSIS

#7763
20110262596
2011-10-27

Carbohydrate And Electrolyte Replacement Composition

#7764
20110262595
2011-10-27

ANTIOXIDANT NUTRITIONAL SUPPLEMENT

#7765
20110262569
2011-10-27

Complex and Manufacturing Method Therefor

#7766
20110262566
2011-10-27

NOVEL USEFUL THERAPEUTIC AGENT FOR LOWER URINARY TRACT SYMPTOM

#7767
20110262563
2011-10-27

Compositions and methods for the prevention and treatment of cardiovascular diseases

#7768
20110262558
2011-10-27

Composition for skin sanitization and protection and method of its use

#7769
20110262552
2011-10-27

Compositions Comprising Plant Extracts and Use Thereof for Treating Inflammation

#7770
20110262543
2011-10-27

PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES

#7771
20110262539
2011-10-27

Pharmaceutical compositions for treating or preventing pain

#7772
20110262538
2011-10-27

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

#7773
20110262533
2011-10-27

Pharmaceutical formulation for use in HIV therapy

#7774
20110262525
2011-10-27

METHODS OF TREATMENT

#7775
20110262503
2011-10-27

Flowable wound matrix and its preparation and use

#7776
20110262496
2011-10-27

Therapeutic formulation for reduced drug side effects

#7777
20110262491
2011-10-27

EMULSIONS AND METHODS OF MAKING NANOCARRIERS

#7778
20110262485
2011-10-27

STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES

#7779
20110262459
2011-10-27

Neamine Compositions and Methods of Use Thereof

#7780
20110262456
2011-10-27

METHOD OF TREATING ISCHEMIA REPERFUSION INJURY

#7781
20110262455
2011-10-27

TREATMENT OF PROLIFERATIVE DISORDERS WITH A DEATH RECEPTOR AGONIST

#7782
20110262448
2011-10-27

Human antibodies that bind mesothelin, and uses thereof

#7783
20110262442
2011-10-27

COMPOSITIONS FOR TREATING CNS DISORDERS

#7784
20110262436
2011-10-27

TREATMENT METHOD

#7785
20110262431
2011-10-27

Pharmaceutical composition comprising antibody composition which specifically binds to CCR4

#7786
20110262422
2011-10-27

ORALLY ADMINISTRABLE DOSAGE FORMS COMPRISING ANGIOGENIN AND USES THEREOF

#7787
20110262417
2011-10-27

Composition useful for the prevention or reduction of the progression of prostate cancer

#7788
20110262409
2011-10-27

Composition comprising a combination of an elder extract and a strain of or

#7789
20110262403
2011-10-27

Method of accelerating osteogenic differentiation and composition thereof

#7790
20110262396
2011-10-27

COMBINATION TREATMENTS COMPRISING PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISORDERS

#7791
20110262390
2011-10-27

COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISORDERS

#7792
20110260684
2011-10-27

Charging device for electric drivable vehicle

#7793
20110259786
2011-10-27

DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF FIBROMYALGIA

#7794
20110257589
2011-10-20

Gas mist pressure bathing cover

#7795
20110257268
2011-10-20

Reduction of sterols and other compounds from oils

#7796
20110257267
2011-10-20

Reducing the Risk of Pathological Effects of Traumatic Brain Injury

#7797
20110257261
2011-10-20

Platinum (IV) complexes for use in dual mode pharmaceutical therapy

#7798
20110257259
2011-10-20

Nut skin products and methods of use thereof

#7799
20110257256
2011-10-20

CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA

#7800
20110257250
2011-10-20

Treating Insulin Secreting Cells